XML 47 R31.htm IDEA: XBRL DOCUMENT v3.22.4
Equity Incentive Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Recognized Compensation Expenses

The Company recognized compensation expense related to the Company plans for the years ended December 31, 2022, 2021 and 2020 as follows (in thousands):

 

 

 

2022

 

 

2021

 

 

2020

 

Stock option plan expense

 

$

552

 

 

$

760

 

 

$

1,141

 

Restricted stock expense

 

$

15,652

 

 

$

18,439

 

 

$

22,755

 

Summary of Options Activity

A summary of the activity of the Company’s stock options plans is presented below:

 

 

 

Shares

 

 

Wtd. Avg.
Exercise
Price

 

 

Wtd. Avg.
Remaining
Contractual
Term (years)

 

 

Aggregate
Intrinsic
Value

 

 

 

(In thousands)

 

 

 

 

 

 

 

 

(In thousands)

 

Options outstanding at January 1, 2022

 

 

1,847

 

 

$

19.92

 

 

 

6.23

 

 

$

73

 

Granted

 

 

342

 

 

 

5.76

 

 

 

 

 

 

 

Exercised

 

 

(10

)

 

 

7.52

 

 

 

 

 

 

 

Forfeited/Canceled

 

 

(294

)

 

 

16.07

 

 

 

 

 

 

 

Options outstanding at December 31, 2022

 

 

1,885

 

 

$

18.03

 

 

 

5.93

 

 

$

2,374

 

Options vested and expected to vest at December 31, 2022

 

 

1,826

 

 

$

18.37

 

 

 

5.85

 

 

$

2,141

 

Options exercisable at December 31, 2022

 

 

1,200

 

 

$

22.94

 

 

 

4.63

 

 

$

212

 

The following table summarizes information relative to stock option activity during the years ended December 31, 2022, 2021 and 2020 (in thousands):

 

 

 

2022

 

 

2021

 

 

2020

 

Intrinsic value of options exercised

 

$

24

 

 

$

-

 

 

$

-

 

Fair value of shares vested

 

$

600

 

 

$

925

 

 

$

1,061

 

Exercise Prices and Related Information of Stock Option Outstanding

The following table summarizes information about the exercise prices and related information of stock options outstanding under the Company plans at December 31, 2022:

 

 

 

Options Outstanding

 

 

Options Exercisable

 

Exercise Prices ($)

 

Number
Outstanding

 

 

Wtd. Avg.
Remaining
Contractual
Life

 

 

Wtd. Avg.
Exercise
Price

 

 

Number
Exercisable

 

 

Wtd. Avg.
Remaining
Contractual
Life

 

 

Wtd. Avg.
Exercise
Price

 

 

 

(In thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

0-18.23

 

 

849

 

 

 

8.11

 

 

$

9.46

 

 

 

214

 

 

 

7.33

 

 

$

12.58

 

18.24-22.26

 

 

439

 

 

 

4.02

 

 

$

20.95

 

 

 

439

 

 

 

4.02

 

 

$

20.95

 

22.27-29.39

 

 

359

 

 

 

4.40

 

 

$

25.31

 

 

 

309

 

 

 

4.07

 

 

$

25.74

 

29.40-45.00

 

 

238

 

 

 

4.06

 

 

$

32.27

 

 

 

238

 

 

 

4.06

 

 

$

32.27

 

Total

 

 

1,885

 

 

 

5.93

 

 

$

18.03

 

 

 

1,200

 

 

 

4.63

 

 

$

22.94

 

Summary of Non-vested Stock Option Activity

The following table summarizes the status of non-vested stock options as of December 31, 2022 and changes during the year ended December 31, 2022:

 

 

 

Number of Shares

 

 

Wtd. Avg. Grant
Date Fair Value

 

 

 

(In thousands)

 

 

 

 

Options non-vested at January 1, 2022

 

 

682

 

 

$

1.79

 

Granted

 

 

342

 

 

 

2.49

 

Vested

 

 

(258

)

 

 

2.32

 

Forfeited

 

 

(294

)

 

 

2.70

 

Options non-vested at December 31, 2022

 

 

472

 

 

$

1.89

 

Summary of Restricted Stock Activity

The following table summarizes the status of restricted stock awards as of December 31, 2022 and changes during the year ended December 31, 2022:

 

 

 

Shares

 

 

Wtd. Avg.
Grant Date
Fair value

 

 

 

(In thousands)

 

 

 

 

Restricted stock outstanding at January 1, 2022

 

 

2,619

 

 

$

12.53

 

Granted

 

 

1,836

 

 

 

6.15

 

Vested

 

 

(807

)

 

 

16.27

 

Forfeited/Canceled

 

 

(53

)

 

 

9.51

 

Restricted stock outstanding at December 31, 2022

 

 

3,595

 

 

$

8.28